Protocol for the examination of specimens from patients with melanoma of the skin

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 10, 2009, Pages 1560-1567

  Frishberg, David P ^a   Balch, Charles ^b,c   Balzer, Bonnie L ^a   Crowson, A Neil ^d   Didolkar, Mikund ^b,e   McNiff, Jennifer M ^f   Perry, Roger R ^g   Prieto, Victor G ^h   Rao, Priya ^a   Smith, M Timothy ⁱ   Smoller, Bruce Robert ^j   Wick, Mark R ^k  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF OKLAHOMA   (United States)

^e Sinai Hospital   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁱ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^j UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^k UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE; SERUM ALBUMIN;

ALBUMIN BLOOD LEVEL; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER LOCALIZATION; CANCER REGRESSION; CANCER SIZE; CLINICAL PROTOCOL; DISEASE CLASSIFICATION; EXCISION; HISTOLOGY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPH NODE METASTASIS; MELANOMA; MICROSATELLITE INSTABILITY; MITOSIS; PATHOLOGY; PERINEURIUM; REVIEW; SENTINEL LYMPH NODE; SKIN BIOPSY; SKIN PIGMENTATION; SKIN ULCER; TUMOR ASSOCIATED LEUKOCYTE; WORLD HEALTH ORGANIZATION;

CLINICAL PROTOCOLS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; PATHOLOGY, SURGICAL; SKIN NEOPLASMS; SOCIETIES, MEDICAL; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 70349640046     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Sober AJ, Chuang TY, Duvic M, et al. Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol. 2001(4);45:579-586. (Pubitemid 32917254)
2. Stell VH, Norton HJ, Smith KS, Salo JC, White RL Jr. Method of biopsy and incidence of positive margins in primary melanoma. Ann Surg Oncol. 2007(2);14:893-898. (Pubitemid 46175340)
3. Sober AJ, Balch CM. Method of biopsy and incidence of positive margins in primary melanoma. Ann Surg Oncol. 2007(2);14:274-275. (Pubitemid 46175266)
4. Smith-Zagone MJ, Schwartz MR. Frozen section of skin specimens. Arch Pathol Lab Med. 2005(12);129:1536-1543.
5. Scolyer RA, Thompson JF, McCarthy SW, Gershenwald JE, Ross MI, Cochran AJ. Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. J Am Coll Surg. 2005(5);201:821823; author reply: J Am Coll Surg. 2005(5);201:823-824.
6. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001(16);19:3622-3634.
7. LeBoit PE BG, Weedon D, Sarasin A, eds. Pathology and Genetics of Skin Tumors. Lyon, France: IARC Press; 2006. World Health Organization Classification of Tumours; vol 10.
8. Fecher LA, Cummings SD, Keefe MJ, Alani RM. Toward a molecular classification of melanoma. J Clin Oncol. 2007(12);25:1606-1620.
9. Becker JC, Kirkwood JM, Agarwala SS, Dummer R, Schrama D, Hauschild A. Molecularly targeted therapy for melanoma: current reality and future options. Cancer 2006(10)107:2317-2327. (Pubitemid 44748514)
10. Edge SE, Byrd DR, Carducci MA, Compton CA, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009.
11. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001(16);19:3635-3648.
12. Balch CM. Cutaneous melanoma: prognosis and treatment results worldwide. Semin Surg Oncol. 1992(6);8:400-414.
13. Barnhill RL, Katzen J, Spatz A, Fine J, Berwick M. The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma. J Cutan Pathol. 2005(4);32:268-273. (Pubitemid 40459928)
14. Harrist TJ, Rigel DS, Day CL Jr, et al. "Microscopic satellites" are more highly associated with regional lymph node metastases than is primary melanoma thickness. Cancer 1984(10)53:2183-2187.
15. Straume O, Akslen LA. Independent prognostic importance of vascular invasion in nodular melanomas. Cancer 1996(6)78:1211-1219. (Pubitemid 26303886)
16. Crowson AN, Magro CM, Mihm MC. Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. Mod Pathol. 2006;19(suppl 2):S71-S87. (Pubitemid 43172310)
17. Balch CM, Murad TM, Soong SJ, Ingalls AL, Halpern NB, Maddox WA. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg. 1978(6);188:732-742.
18. Lefevre M, Vergier B, Balme B, et al. Relevance of vertical growth pattern in thin level II cutaneous superficial spreading melanomas. Am J Surg Pathol. 2003(6);27:717-724. (Pubitemid 36617508)
19. Bedrosian I, Faries MB, Guerry D 4th, et al. Incidence of sentinel node metastasis in patients with thin primary melanoma (≤1 mm) with vertical growth phase. Ann Surg Oncol. 2000(4);7:262-267. (Pubitemid 30318313)
20. Gershenwald JE, Andtbacka RH, Prieto VG, et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol. 2008;26(26):4296-4303.
21. van Akkooi AC, Nowecki ZI, Voit C, et al. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. Ann Surg. 2008;248(6):949-955.
22. Dewar DJ, Newell B, Green MA, Topping AP, Powel B, Cook MG. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004 August 15;22(16):3345-3349. (Pubitemid 41103692)
23. Starz H, Siedlecki K, Balda BR. Sentinel lymphonodectomy and S-Classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol. 2004;11(3)(suppl):162S-168S.
24. National Comprehensive Cancer Network (NCCN). Melanoma. http://www.nccn.org/professionals/physician-gls/PDF/melanoma.pdf. Accessed April 3, 2009.
25. Sobin LH, Gospodarowicz M, Wittekind Ch, eds, for International Union Against Cancer. TNM Classification of Malignant Tumours. 7th ed. New York, NY: Wiley-Liss; In press.
26. Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer. 2003;98(12):2740-2741. (Pubitemid 37509544)
27. Scheri RP, Essner R, Turner RR, Ye X, Morton DL. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol. 2007;14(10):2861-2866. (Pubitemid 47460638)
28. Buzaid AC, Tinoco LA, Jendiroba D, et al. Prognostic value of size of lymph node metastases in patients with cutaneous melanoma. J Clin Oncol. 1995;13(9):2361-2368.
29. Schuchter LM. Review of the 2001 AJCC staging system for cutaneous malignant melanoma. Curr Oncol Rep. 2001;3(4):332-337.
30. Eton O, Legha SS, Moon TE, et al. Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol. 1998;16(3):1103-1111. (Pubitemid 28108747)